HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Chronic Incretin-based therapy in Cystic Fibrosis (Aim 2)
This study is no longer recruiting.
The purpose of this research study is to examine and understand the various mechanisms that contribute to Cystic Fibrosis Related Diabetes and gain a better understanding of potential means to treat Cystic Fibrosis Related Diabetes. Participation will include 6-7 visits over 6 months.
Eligibility & Criteria
IRB #:
13-010324
Official Title:
A Randomized, Double Blind, Placebo Controlled Study of the Effectiveness of Chronic Incretin-based therapy on Insulin Secretion in Cystic Fibrosis
Study Phase:
Phase II
Eligible Age Range:
18 - 99 Years
Gender:
All
Study Categories:
Leader
